Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BIO Notebook, Day 4: Annual Convention Winds Down With Oncology In The Spotlight

Jun 23 2017

• By Mandy Jackson

Cancer-cells-pink-color_1200x675

Related Content

FINANCE ROUNDUP: A New VC Fund, A $60m Collaboration Boost, And 14 Funding Rounds

Nov 19 2015

Vaximm Seeks Pharma Partners For T-Cell/Checkpoint Inhibitor Combos

Dec 29 2016

Merck To Get Chronic Cough P2X3 Inhibitor Candidate With Afferent Buy

Jun 10 2016

BioNotebook: Four deal updates, a venture funding round and a milestone fee

Dec 05 2014

Finance Watch: Bicycle Spins Toward Clinic With $52m Round; Stock Spikes Spur Offerings

Jun 02 2017

Related Companies

Akamis Bio

Bicycle Therapeutics, plc

Cogent Biosciences, Inc.

Immune Design Corporation

Atreca, Inc.

Vaximm AG

Merck & Co., Inc.

Johnson & Johnson

Merck KGaA

Pfizer Inc.

Afferent Pharmaceuticals

Teijin Medical Technologies Co., Ltd.

Additional Topics

ImmunoOncology Business Strategies Deals Clinical Trials Commercial Financing Cancer BioPharmaceutical

More from Immuno-oncology

More from Anticancer

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window